Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes

European Journal of Pharmacology

Volumn 401, Issue 3, 2000, Pages 381-388

  Bäck, Magnus ^b   Norel, Xavier ^a   Walch, Laurence ^a   Gascard, Jean Pierre ^a   Mazmanian, Guy ^a   Dahlén, Sven Erik ^b   Brink, Charles ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

BAY u9773; Contraction; CysLT receptor; ICI 204,219; Leukotriene; Pulmonary artery, porcine

Indexed keywords

6 (4 CARBOXYPHENYLTHIO) 5 HYDROXY 7,9,11,14 ICOSATETRAENOIC ACID; INDOMETACIN; LEUKOTRIENE C4; LEUKOTRIENE D4; PEPTIDOLEUKOTRIENE; ZAFIRLUKAST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY; RECEPTOR POTENTIAL; SWINE;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; CYSTEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; INDOMETHACIN; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENES; MALE; MEMBRANE PROTEINS; PULMONARY ARTERY; RECEPTORS, LEUKOTRIENE; SRS-A; SWINE; THROMBOXANE A2; TOSYL COMPOUNDS; VASOCONSTRICTION;

EID: 0343867287     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00452-0     Document Type: Article

References (33)

1. 4 in the guinea pig ileum. Eur. J. Pharmacol. 317:1996;107-113.
2. Bäck M., Norel X., Walch L., Gascard J.P., de Montpreville V., Dahlén S.E., Brink C. Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes. Eur. J. Pharmacol. 401:2000;389-395.
3. Berkowitz B.A., Zabko-Potapovich B., Valocik R., Gleason J. Effects of the leukotrienes on the vasculature and blood pressure of different species. J. Pharmacol. Exp. Ther. 229:1984;105-112.
4. 4. Fundam. Clin. Pharmacol. 1:1987;433-444.
5. Brink C., Duncan P.G., Douglas J.S. The lung parenchymal strip: a reappraisal. J. Pharmacol. Exp. Ther. 219:1981;1-6.
6. 4. J. Pharmacol. Exp. Ther. 237:1986;558-562.
7. Buckner C.K., Fedyna J.S., Robertson J.L., Will J.A., England D.M., Krell R.D., Saban R. An examination of the influence of the epithelium on contractile responses to peptidoleukotrienes and blockade by ICI 204,219 in isolated guinea pig trachea and human intralobar airways. J. Pharmacol. Exp. Ther. 252:1990;77-85.
8. Capra V., Nicosia S., Ragnini D., Mezzetti M., Keppler D., Rovati G.E. Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. Mol. Pharmacol. 53(4):1998;750-758.
9. Coleman R.A., Eglen R.M., Jones R.L., Narumiya S., Shimizu T., Smith W.L., Dahlén S.E., Drazen J.M., Gardiner P.J., Jackson W.T., Jones T.R., Krell R.D., Nicosia S. Prostanoid and leukotriene receptors: a progress report from the IUPHAR working parties on classification and nomenclature. Adv. Prostaglandin, Thromboxane, Leukotriene Res. 23:1995;283-285.
10. Drazen J.M., Austen K.F., Lewis R.L., Clark D.A., Goto G., Marfat A., Corey E.J. Comparative airway and vascular activities of leukotriene C-1 and D in vivo and in vitro. Proc. Natl. Acad. Sci. 77:1980;4354-4358.
11. 4 receptors in smooth muscle. Life Sci. 31:1982;557-581.
12. 4 in the pulmonary vascular bed. Circ. Res. 55:1984;707-717.
13. Krell R.D. The emergence of potent and selective peptide leukotriene receptor antagonists. Pulm. Pharmacol. 2:1989;27-31.
14. Krell R.D., Aharony D., Buckner C.K., Keith R.A., Kusner E.J., Snyder D.W., Bernstein P.R., Matassa V.G., Yee Y.K., Brown F.J., Hesp B., Giles R.E. The preclinical pharmacology of ICI 204,219. Am. Rev. Respir. Dis. 141:1990;978-987.
15. Labat C., Ortiz J.L., Norel X., Gorenne I., Verley J., Abram T.S., Cuthbert N.J., Tudhope S.R., Norman P., Gardiner P., Brink C. A second cysteinyl leukotriene receptor in human lung. J. Pharmacol. Exp. Ther. 263:1992;800-805.
16. Lawrence R.N., Clelland C., Beggs D., Salama F.D., Dunn W.R., Wilson V.G. Differential role of vasoactive prostanoids in porcine and human pulmonary arteries in response to endothelium-dependent relaxants. Br. J. Pharmacol. 125:1998;1128-1137.
17. Leffler C.W., Mitchell J.A., Green R.S. Cardiovascular effects of leukotrienes in neonatal piglets, role in hypoxic vasoconstriction? Circ. Res. 55:1984;780-787.
18. 1 receptor. Nature. 399:1999;789-793.
19. Ohtaka H., Tsang J.Y., Foster A., Hogg J.C., Schellenberg R. Comparative effects of leukotrienes on porcine pulmonary circulation in vitro and in vivo. J. Appl. Physiol. 63:1987;582-588.
20. Olson N.C., Fleisher L.N. Indomethacin and LY171883 modify porcine cardiopulmonary responses to leukotrienes. Prostaglandins, Leukotrienes Essent. Fatty Acids. 35:1989;175-182.
21. Ortiz J.L., Gorenne I., Cortijo J., Seller A., Labat C., Sarria B., Abram T.S., Gardiner P.J., Morcillo E., Brink C. Leukotriene receptors on human pulmonary vascular endothelium. Br. J. Pharmacol. 115:1995;1382-1386.
22. 4. J. Appl. Physiol. 64:1988;435-440.
23. Pradelles P., Grassi J., Maclouf J. Enzyme immunoassays of eicosanoids using acetylcholine esterase as label: an alternative to radioimmunoassay. Anal. Chem. 57:1985;1170-1173.
24. 4 in membranes from human lung. Biochem. Pharmacol. 34(16):1985;2831-2837.
25. Sarau H.M., Ames R.S., Chambers J., Ellis C., Elshourbagy N., Foley J.J., Schmidt D.B., Muccitelli R.M., Jenkins O., Murdock P.R., Herrity N.C., Halsey W., Sathe G., Muir A.I., Nuthulaganti P., Dytko G.M., Buckley P.T., Wilson S., Bergsma D.J., Hay D.W. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol. Pharmacol. 56:1999;657-663.
26. Schellenberg R.R., Foster A. Differential activity of leukotrienes upon human pulmonary vein and artery. Prostaglandins. 27:1984;475-482.
27. 4 affects pulmonary and cardiovascular dynamics in monkey. Nature. 295:1982;327-329.
28. 4 receptor in guinea pig trachea. J. Pharmacol. Exp. Ther. 231:1984;616-622.
29. Tudhope S.R., Cuthbert N.J., Abram T.S., Jennings M.A., Maxey R.J., Thompson A.M., Norman P., Gardiner P.J. BAY u9773, a novel antagonist of cysteinyl-leukotrienes with activity against two receptor subtypes. Eur. J. Pharmacol. 264:1994;317-323.
30. Wikström Jonsson E. Functional characterization of receptors for cysteinyl-leukotrienes in sheep trachealis muscle. Pulm. Pharmacol. Ther. 10:1997;29-36.
31. Wikström Jonsson E., Rosenqvist U., Dahlén S.E. Agonist and antagonist activities of the leukotriene analogue BAY u9773 in the guinea pig lung parenchyma. Eur. J. Pharmacol. 357:1998;203-211.
32. Zellers T.M., McCormick J., Wu Y. Interaction among ET-1, endothelium-derived nitric oxide and prostacyclin in pulmonary arteries and veins. Am. J. Physiol. 36:1994;H139-H147.
33. 4 receptor antagonist in the pig. Eicosanoids. 3:1991;219-224.